Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096926 · ClinicalTrials.gov registry record · Phase 4
Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery
A Phase 4 study, sponsored by Lotus Clinical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT02096926: Completed Phase 4 study, sponsored by Lotus Clinical Research.
NCT02096926 is a Phase 4 study that has completed, run by Lotus Clinical Research. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02096926, a Phase 4 study, has completed, sponsored by Lotus Clinical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a single center placebo controlled, prospective, randomized study on healthy adults undergoing third molar surgery.
Interventions
- DRUG Placebo
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
What the finished NCT02096926 record still lists
NCT02096926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02096926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02096926 about?
NCT02096926 is a clinical study titled "Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery". This is a single center placebo controlled, prospective, randomized study on healthy adults undergoing third molar surgery.
What is the current status of trial NCT02096926?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2014-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02096926?
The interventions under investigation include: Placebo (DRUG), Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT02096926?
This trial is sponsored by Lotus Clinical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02096926's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia